Acorah Software Products - Accounts Production 16.8.310 false true false true No description of principal activity 24 May 2024 31 May 2025 31 May 2025 15741397 Mr Nasir Choudhury iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15741397 2024-05-23 15741397 2025-05-31 15741397 2024-05-24 2025-05-31 15741397 frs-core:CurrentFinancialInstruments 2025-05-31 15741397 frs-bus:PrivateLimitedCompanyLtd 2024-05-24 2025-05-31 15741397 frs-bus:FilletedAccounts 2024-05-24 2025-05-31 15741397 frs-bus:Micro-entities 2024-05-24 2025-05-31 15741397 frs-bus:AuditExempt-NoAccountantsReport 2024-05-24 2025-05-31 15741397 frs-bus:Director1 2024-05-24 2025-05-31
Registered number: 15741397
Curative Medical Limited
Unaudited Financial Statements
For the Period 24 May 2024 to 31 May 2025
Curative Medical Limited
Balance Sheet
As At 31 May 2025
Balance Sheet
Registered number: 15741397

| 31 May 2025
--- | ---
|  | £
Fixed assets |  | 721
Current assets |  | 5,605
Creditors: Amounts Falling Due Within One Year |  | (4,266 )
NET CURRENT ASSETS |  | 1,339
TOTAL ASSETS LESS CURRENT LIABILITIES |  | 2,060
Accruals and deferred income |  | (643 )
NET ASSETS |  | 1,417
CAPITAL AND RESERVES |  | 1,417

## Notes

1. General Information
Curative Medical Limited is a private company, limited by shares, incorporated in England & Wales, registered number 15741397 . The registered office is 20 Craig Drive, Uxbridge, UB8 3HL.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
For the period ending 31 May 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board

Mr Nasir Choudhury Director
24/02/2026